TOKYO, Apr 28 (Pulse News Wire) – Sysmex Corporation (6869.T) reported a fourth quarter impairment loss of ¥11.56 billion, impacting its overall fiscal year 2026 earnings forecast. The impairment primarily stems from reassessing goodwill recognized during acquisitions of subsidiaries Sysmex Partec GmbH, Oxford Gene Technology IP Limited, and Sysmex Astrego AB.
As a result, the company revised its full-year outlook for the fiscal year ending March 31, 2026. Compared to previous estimates, the adjusted figures show a decline across key metrics: | Metric | Previous Estimate (A) | Current Estimate (B) | Change (B-A) | |--------------------|-------------------------|-----------------------|---------------------| | Revenue | ¥500.0 billion | ¥500.0 billion | ---¥11.00 billion | | Operating Profit | ¥62.00 billion | ¥51.00 billion | ---¥10.00 billion | | Pre-tax Income | ¥59.00 billion | ¥49.00 billion | ---¥6 billion | | Net Income | ¥41.00 billion | ¥35.00 billion | - | The revisions reflect a decrease in operating profit, pre-tax income, and net income by -17.7%, -16.9%, and -14.6%, respectively.
Regarding dividends, there have been no changes since the last announcement on May 14, 2025.
🟢 Confidence: High AI-translated content.